Pictet Asset Management (Switzerland)’s bluebird bio BLUE Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$15.4M	Buy	233,341 +78,103	+50%	+$5.71M	0.02%	525
2023 Q1	$9.87M	Buy	155,238 +100,685	+185%	+$11.5M	0.01%	620
2022 Q4	$7.55M	Buy	54,553 +13,699	+34%	+$1.93M	0.01%	650
2022 Q3	$5.17M	Buy	40,854 +5,210	+15%	+$589K	0.01%	731
2022 Q2	$2.95M	Buy	35,644 +20,311	+132%	+$1.58M	﹤0.01%	876
2022 Q1	$1.49M	Buy	15,333 +3,678	+32%	+$485K	﹤0.01%	1002
2021 Q4	$2.33M	Sell	11,655 -2,978	-20%	-$703K	﹤0.01%	980
2021 Q3	$3.62M	Buy	+14,633	New	+$4.18M	﹤0.01%	910

Other funds holding BLUE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s BLUE Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its bluebird bio (BLUE) stake by 50% in Q2 2023, buying an estimated $5.71M and bringing the position to 233,341 shares worth $15.4M. The position accounts for 0.02% of the portfolio, ranked #525.

Pictet Asset Management (Switzerland) first reported a position in BLUE in Q3 2021 and has held it in 8 quarters since. 175 funds tracked by Wall St. Rank hold BLUE as of Q2 2023.

Pictet Asset Management (Switzerland) held 233,341 shares of bluebird bio worth $15.4M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 78,103 bluebird bio shares in Q2 2023, an estimated $5.71M.
bluebird bio made up 0.02% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #525 holding.
Pictet Asset Management (Switzerland) first reported a position in bluebird bio in Q3 2021 and has held it in 8 quarters since.
175 funds tracked by Wall St. Rank held bluebird bio as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.